Hsp90 inhibitor shows NSCLC promise
Treatment with a heatshock protein 90 inhibitor may induce loss of EML4-AKL expression in non-small cell lung cancer cells, preliminary results suggest.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine